Aeklvya Advisors Research
Advisory Approach
Aeklvya Advisors is a boutique strategic advisory firm founded in 2020 with a clear purpose: to serve entrepreneur-led, family-owned businesses, and midsized companies that require thoughtful, individualized guidance often unavailable from larger, more institutional firms. The firm operates with a philosophy drawn from the Mahabharata, combining Eklavya's disciplined mastery with Krishna's strategic wisdom—emphasizing careful analysis, independent thinking, and practical guidance.
The firm brings a deliberately customized perspective to questions of value, long-term direction, and complex business decisions. Unlike larger institutional firms, Aeklvya explicitly avoids standardized frameworks and one-size-fits-all solutions. Every engagement begins with deep understanding of the business, its people, and the objectives that matter most to owners. The advisory thesis centers on the belief that trusted relationships are built on integrity, independence, and clarity. Clients work directly with experienced advisors who take time to listen, challenge assumptions, and provide candid, unbiased perspectives. The firm's size and structure enable it to remain agile and responsive, offering senior-level attention without unnecessary organizational layers.
Aeklvya positions itself as a long-term strategic partner, helping owners navigate important decisions with confidence, context, and clear understanding of options—always with owner interests at the forefront. The firm's focus is on insight and preparation rather than execution, enabling business owners to make informed decisions aligned with their goals and risk preferences.
Sector Focus
Aeklvya maintains specialized expertise across healthcare, life sciences, medical devices, diagnostics, pharmaceuticals, technology, business services, and industrial sectors. The firm's primary vertical is healthcare and life sciences, where it demonstrates particular depth in multiple sub-segments.
Within medical devices and technology, the firm advises on precision medical instrumentation, diagnostic devices, and healthcare technology platforms. This includes companies developing innovative medical device solutions, point-of-care testing equipment, diagnostic imaging technologies, and healthcare software platforms that improve patient outcomes or clinical workflows.
In diagnostics and consumables, Aeklvya specializes in clinical laboratory services, diagnostic reagent manufacturers, immunoassay platforms, molecular diagnostics, and pathology services. The firm understands the regulatory landscape, reimbursement dynamics, and consolidation trends in diagnostic services.
The contract pharma services vertical represents work with contract manufacturing organizations (CMOs), contract development and manufacturing organizations (CDMOs), pharmaceutical formulation specialists, and outsourced regulatory services providers. The firm advises companies navigating outsourcing relationships, capacity planning, and commercial scaling in the CDMO market.
Healthcare IT and pharma consulting encompasses digital health platforms, electronic health record (EHR) implementations, healthcare data analytics, pharma consulting firms advising on clinical development and regulatory strategy, and business intelligence platforms serving healthcare organizations.
Beyond healthcare, the firm also maintains active practices in technology (particularly healthcare-adjacent software and digital health), business services (staffing, outsourced services), consumer-facing health and wellness brands, and industrial companies with healthcare applications. This breadth reflects the firm's ability to apply its core advisory methodology across sectors while maintaining credibility in healthcare as its anchor vertical.
Advisory Services and Engagement Model
Aeklvya's service offerings center on three core capabilities: Strategic Advisory, Value Driver Assessment, and Business Valuation.
Strategic Advisory engagements help business owners and leadership teams think clearly about value creation, long-term direction, and critical corporate decisions. The firm works with clients to assess where the business stands today, identify core strengths and constraints, and understand the market and competitive landscape. This foundational assessment enables development of tailored strategic perspectives aligned with each owner's objectives, risk tolerance, and long-term aspirations. The firm's work is supported by rigorous market and industry research, thoughtful analysis, and global experience, providing clients the foundation to make informed, independent decisions at pivotal moments.
Value Driver Assessment work helps business owners understand what truly drives enterprise value within their organization—across financial performance, operations, market positioning, and organizational structure. The firm identifies key levers influencing value creation and evaluates how those drivers perform relative to peers and industry benchmarks. Analysis highlights strengths to reinforce, gaps to address, and risks to manage, providing owners with a prioritized view of where management focus can have the greatest impact. This creates a practical framework supporting better strategic planning and long-term decision-making.
Business Valuation services provide independent valuation opinions designed for strategic planning and long-term decision-making. The firm's analyses help management and business owners understand how their business performs under different scenarios and how changes in operations, growth strategy, or market conditions influence overall value. Aeklvya emphasizes transparency and context, combining financial analysis with qualitative factors such as business model resilience, customer concentration, competitive positioning, and scalability. The objective is to equip owners with clear, defensible understanding of value to support thoughtful, informed strategic choices. The firm explicitly rejects formulaic or off-the-shelf approaches, recognizing that no two businesses are identical and requiring valuation work tailored to each company's unique operating model, growth profile, risk characteristics, and market context.
Team and Experience
The firm is led by founder and Managing Director Leo Fernandez, who brings deep expertise in strategic advisory and M&A. The team is compact—2-10 professionals—but strategically composed to ensure senior-level expertise on every engagement. This structure allows the firm to maintain the agility and responsiveness critical to its value proposition while avoiding the overhead and bureaucracy of larger institutions.
Manish Kumar serves as President and brings extensive investment banking and M&A advisory experience. Kumar is FINRA-registered with Series 79 and Series 63 certifications, qualifying him for investment banking and securities representation work. His background includes roles at several investment banking and advisory firms including Independent Investment Bankers Corp (2020-2024), Cuttone & Co. (2019-2020), and Achelous Partners (2018-2019). Kumar's experience spans M&A advisory, valuation, and strategic consulting for mid-market companies. His registration and certifications underscore the firm's institutional credibility in securities and investment banking matters.
The team's composition emphasizes experience over headcount, with each professional expected to bring senior-level expertise and client access. This approach aligns with the firm's positioning as offering "senior-level attention without unnecessary layers."
Competitive Positioning
Aeklvya differentiates from other advisory firms through several distinct positioning points:
Bespoke advisory tailored to owner circumstances. While many firms apply standardized frameworks and boilerplate approaches, Aeklvya explicitly customizes every engagement. The firm understands that founder-led and family-owned businesses face unique challenges—balancing growth with family dynamics, planning for leadership transitions, and aligning strategy with personal ownership objectives. The firm's approach reflects this reality.
Senior-level access without institutional overhead. Boutique structure means founders work directly with experienced advisors rather than navigating layers of junior analysts and associates. This reduces friction in communication and decision-making.
Independence and unbiased perspective. The firm positions itself as a trusted advisor, not a deal facilitator. This independence is explicitly highlighted as differentiator. The firm's revenue model (strategic advisory and valuations rather than transaction-based fees) enables the firm to provide candid, unbiased guidance without incentive to push particular outcomes.
Integrated healthcare expertise. While willing to serve companies across sectors, the firm's anchor vertical is healthcare and life sciences. The depth of sectoral expertise—understanding regulatory landscape, reimbursement dynamics, competitive positioning, M&A precedents—differentiates from generalist advisors.
Business Model and Philosophy
Aeklvya's business model is built on strategic advisory, valuation, and consulting engagements rather than transaction-contingent fees. This structure creates alignment with clients focused on strategic clarity and long-term value creation rather than closing deals. The firm likely operates on retainer or project-based fee arrangements, though specific fee structure is not publicly disclosed.
The philosophical foundation emphasizes that "no two businesses are the same" and rejects one-size-fits-all solutions. The firm appeals to business owners seeking independent, candid guidance from advisors who understand their specific circumstances—rather than standardized recommendations. This positioning particularly resonates with founder-led and family-owned businesses where personal and business objectives are intertwined.
Geographic and Market Context
Based in New York with headquarters in Midtown Manhattan, Aeklvya serves global midmarket companies. The firm's ability to advise globally—particularly in healthcare and life sciences—reflects the sector's multinational nature and the prevalence of cross-border transactions in pharma, medical devices, and diagnostics. The firm's focus on small and mid-cap businesses ($10M-$250M estimated range) positions it in the lower middle market segment where specialized advisory firms thrive by offering senior expertise without the complexity and cost of major investment banks.
Market Trends and Sector Dynamics
The firm operates in healthcare and life sciences sectors experiencing significant M&A activity. Healthcare consolidation continues across multiple segments: physician services, outpatient centers, clinical laboratories, diagnostic imaging, CDMO/outsourced services, and healthcare technology. The firm's positioning in strategic advisory and valuation makes it particularly relevant for business owners evaluating whether and how to participate in this consolidation landscape.
In pharmaceuticals and life sciences, outsourcing to CDMOs and contract research organizations (CROs) is accelerating, creating M&A activity among outsourced service providers. The firm's expertise in CDMO and pharma services positioning is timely given capital deployment in this space.
Healthcare technology consolidation—driven by digital health adoption, data analytics, and interoperability initiatives—creates advisory opportunities for healthcare software and healthcare IT service providers.
Sweet Spot and Engagement Profile
The firm's sweet spot consists of founder-owned and family-owned businesses in healthcare, life sciences, medical devices, diagnostics, and related sectors. Ideal clients are:
- Businesses with enterprise values between $10M-$250M
- Owner-led organizations where founder/family objectives drive strategy
- Companies at inflection points: planning exits, evaluating partnerships, positioning for consolidation, or assessing recapitalization
- Businesses requiring sophisticated strategic guidance but not transaction-contingent advice
- Companies valuing candid, unbiased perspective from advisors without hidden agendas
The firm is not optimized for pure M&A deal execution (sell-side processes with active buyer outreach), but rather for strategic clarity, valuation preparation, and long-term decision-making support.